Molnlycke

Molnlycke's reported carbon emissions

Mölnlycke, a pharmaceutical preparation manufacturing company headquartered in Sweden, has set ambitious climate targets. For 2025, Mölnlycke reported total emissions of approximately 533.1 million kg CO2e. This breaks down into about 47.9 million kg CO2e for Scope 1, approximately 1.9 million kg CO2e for Scope 2 (market-based), and around 483.3 million kg CO2e for Scope 3. The largest contributor within Scope 3 emissions is purchased goods and services, accounting for approximately 295.1 million kg CO2e. In 2024, total emissions were approximately 548.8 million kg CO2e, with Scope 1 at about 40 million kg CO2e, Scope 2 at approximately 10 million kg CO2e (market-based), and Scope 3 at around 480 million kg CO2e. Mölnlycke has committed to ambitious reduction targets: * **Reduce absolute Scope 1 and 2 GHG emissions by 50% by 2030**, using a 2021 baseline year. * **Increase active annual sourcing of renewable electricity from 23% in 2021 to 100% by the end of 2024**, and maintain this level through 2030. * **Reduce absolute Scope 3 GHG emissions from purchased goods and services, fuel and energy-related activities, upstream transportation and distribution, and waste generated in operations by 20% by 2028**, against a 2021 baseline. * **Ensure that 63% of its suppliers, by emissions, will have science-based targets by 2028.** * **Achieve net-zero greenhouse gas emissions across the value chain by 2050.** The company's Scope 1 and 2 targets are considered consistent with the reductions needed to keep global warming to 1.5°C. Mölnlycke is working towards these goals, with some targets currently being met or on track.